 |
 Video: What is a Stock Split?
|
|
|
| Calithera Biosciences is a clinical-stage bio-pharmaceutical company focused on fighting cancer and other life threatening diseases by discovering and developing small molecule drugs that targets cellular metabolism. Co.'s main product candidate, telaglenastat (CB-839), is a selective glutaminase inhibitor that blocks glutamine consumption in tumor cells and demonstrates synergistic antitumor effects with multiple anticancer therapies.Co.'s other product candidate, INCB001158, is an oral inhibitor of arginase, an enzyme that depletes the amino acid arginine, a key metabolic nutrient for T-cells and it is being co-developed with Incyte Corporation, for oncology and hematology indications. According to our CALA split history records, Calithera Biosciences has had 1 split. |
|
|
Calithera Biosciences (CALA) has 1 split in our CALA split history database. The split for CALA took place on July 17, 1996. This was a 2 for 1
split, meaning for each share of CALA owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split.
When a company such as Calithera Biosciences splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the CALA split history from start to finish, an original position size of 1000 shares would have turned into 2000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Calithera Biosciences shares, starting with a $10,000 purchase of CALA, presented on a split-history-adjusted basis factoring in the complete CALA split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
10/02/2014 |
|
| End date: |
08/03/2020 |
|
| Start price/share: |
$9.41 |
|
| End price/share: |
$4.87 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-48.25% |
|
| Average Annual Total Return: |
-10.66% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$5,176.72 |
|
| Years: |
5.84 |
|
|
|
| Date |
Ratio |
| 07/17/1996 | 2 for 1
|
|
|
